Table 3.
Study | n | Treatment | Patient Characteristics | Effect on Output | Closure Rate | Time to Closure |
---|---|---|---|---|---|---|
ECF, enterocutaneous fistula; NA, not applicable; NS, not significant; O, octreotide; Pl, placebo; PO, postoperative; S, somatostatin-14; TPN, total parenteral nutrition. | ||||||
Nubiola-Calonge et al45 | 6 | Pl, O, O | PO, ECF | p < .01 | No effect | NA |
8 | O, Pl, O | |||||
Scott et al46 | 8 | Pl | PO, ECF | NS | No effect | NA |
1 | O | |||||
1 | ||||||
Sancho et al47 | 1 | Pl + TPN | PO, mixed | NS | No effect | No change |
7 | O + TPN | |||||
1 | ||||||
4 | ||||||
Hernandez-Aranda et al48 | 4 | TPN | PO, ECF | NA | No effect | Shorter |
5 | O + TPN | |||||
4 | ||||||
0 |